Lung Cancer Therapeutics Market to Surpass 61 Billion USD by 2032

New York, Monday, 1 September 2025.
Driven by precision medicine advancements, the U.S. lung cancer therapeutics market will grow from 9.51 billion USD in 2024 to 15.86 billion USD by 2032, revolutionizing treatment.